Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients

Background/Purpose: The long-acting corifollitropin alfa is comparable to FSH in terms of pregnancy outcomes in normal responders and poor responders. Corifollitropin alfa has never been studied in polycystic ovary syndrome (PCOS) patients because of concerns of excessive ovarian stimulation and ova...

Full description

Bibliographic Details
Main Authors: Jiann-Loung Hwang, Shee-Uan Chen, Hen-Ju Chen, Hsin-Fu Chen, Yu-Shih Yang, Chin-Hao Chang, Kok-Min Seow, Chii-Ruey Tzeng, Yu-Hung Lin
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Journal of the Formosan Medical Association
Online Access:http://www.sciencedirect.com/science/article/pii/S092966461730013X